Timothy Schell: Leading the FDA's Veterinary Efforts

Timothy Schell is a prominent figure in the field of veterinary medicine. He currently holds the position of acting director at the FDA's Center for Veterinary Medicine. His leadership is pivotal to the agency's efforts in addressing the challenges faced by the nation's livestock industry.

Current Role

In his capacity as acting director, Schell is responsible for overseeing the review and approval process of animal drugs. This role is particularly significant as the FDA continues to expedite these reviews to combat threats to livestock and, by extension, the livelihoods of farmers and ranchers across the United States.

Impact and Initiatives

Schell has been vocal about the FDA's commitment to supporting the agricultural sector through timely and effective drug approvals. This initiative is aimed at ensuring the health and productivity of livestock, which is a critical component of the U.S. economy and food supply chain. He emphasized the commitment to ensuring the safety and effectiveness of animal drugs. As director, he has also emphasized the importance of including wildlife in the authorization to prevent the spread of screwworm, demonstrating a comprehensive approach to animal health. Schell commented on the decision to expand generic options for dealing with New World screwworm.